IMNM
Immunome, Inc.
Stock
$20.90+0.01 (+0.05%)Close Oct 2, 2026
- Revenue, 2025
- $6.9M
- YoY, 2025
- −23.2%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $6.9M | −23.2% |
| 2024 | $9.0M | −35.5% |
| 2023 | $14M | — |
Immunome, Inc.
$20.90+0.01 (+0.05%)Close Oct 2, 2026
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $6.9M | −23.2% |
| 2024 | $9.0M | −35.5% |
| 2023 | $14M | — |